Blood Gas and Electrolyte Analyzers Market Size By Modality (Bench Top, Portable), By Product (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers, Consumables), By End-use (Central Laboratories, Point-of-care, Diagnostic Centers, Hospitals), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022– 2028

Industry Trends

Blood Gas and Electrolyte Analyzers Market Size exceeded USD 1.5 billion in 2021 and is anticipated to grow at a CAGR of over 5.1% from 2022 to 2028. Rising demand for point of care and automated blood gas analyzers coupled with the integration of blood gas analyzers with laboratory information systems and electronic medical records will positively impact the market growth. Furthermore, increasing patient population in critical care units and collaboration between the public and private sectors with healthcare facilities are some of the major factors that are expected to facilitate the market expansion.
 

Get more details on this report - Request Free Sample PDF
 

COVID-19 pandemic positively impacted the blood gas and electrolyte analyzers market. As amid pandemic several surgeries were postponed, and non-emergency hospitalization were cancelled it impacted the market moderately. However, there was rise witnessed in hospitalization rate of people suffering with COVID-19. Surging cases of COVID-19 pandemic has increased demand for blood gas and electrolyte analyzers in hospitals, clinics, point of care centers will positively influence the industry growth.

Blood gas and electrolyte analyzers are used to measure different parameters from whole blood samples, such as electrolytes, metabolites, pH, and blood gas including SpCO2 and SpO2. These analyzers also measure partial pressure of oxygen, carbon dioxide, and concentrations of many ions including potassium, sodium, bicarbonate, chloride, calcium, glucose, lactate, magnesium. These analyzers are easy-to-use, effective and give assured results in less time.
 

Rising geriatric population susceptible to chronic diseases will boost the industry expansion

Increasing disease burden along with rapidly growing geriatric population base in developing regions will substantially impact the blood gas and electrolyte analyzers market progression. Moreover, geriatric population is more susceptible to several infectious and chronic diseases. The treatment of these disorders relies on the accurate examination of blood samples in a timely manner. As a result, the number of patients receiving critical care in emergency rooms has increased.
 

Convenience in use of portable blood gas and electrolyte analyzers to augment the market value

The portable analyzer segment dominated more than 64% of the blood gas and electrolyte analyzers market share in 2021 led by the growing adoption of portable devices coupled with rising demand for point-of-care blood gas and electrolyte analyzers. These devices are handy, cost-effective, easy to use, and give rapid results. Also, they do not require any skilled physician to work. Furthermore, technological advancement in blood gas and electrolyte analysis devices will also drive the industry progression during the forecast period.
 

Increasing use of consumables will spur the market demand

Get more details on this report - Request Free Sample PDF
 

The consumables segment in the blood gas and electrolyte analyzers market valued at USD 874 million in 2021. Consumables include components like reagent, cartridges, electrodes, test strips, batteries, etc. These components are required in analyzers on daily basis to carry out test. This increases the demand of consumables within the suppliers. Also rising innovative product launch and growing demand for solutions and quality control reagents will upsurge the industry value.

 

Growing acceptance of technologically advanced equipment in hospitals for treatment purpose to accelerate the market revenue

The blood gas and electrolyte analyzers market for hospitals segment captured 12% of revenue share in 2021 owing to the increasing healthcare expenditure to provide improved patient care along with large number of treatment procedures conducted in hospitals. Hospitals are equipped with ICUs, and emergency departments, where blood gas and electrolyte analyzers are used to detect various health parameter in patients’ body.
 

Rising prevalence of chronic disorders in North America region will stimulate the market growth

Get more details on this report - Request Free Sample PDF
 

North America blood gas and electrolyte analyzers market accounted for 37% of revenue share in 2021. High regional growth in the U.S. and Canada is attributed to well-developed healthcare facilities and availability of several treatment options and presence of major market player in this region. The increasing demand for point-of-care devices with wireless connectivity that are easy to carry is also poised to propel the market in the coming years. Moreover, rising prevalence of lifestyle diseases such as obesity, diabetes also calls for regular checkup which increases the use of analyzers.
 

Innovative strategies by key players will upsurge growth opportunities in market

Some of the key companies operating in the market include Abbott, Convergent Technologies GmbH & Co. KG, Sensa Core, Edan Instruments, Inc., Erba Mannheim, F. Hoffmann-La Roche Ltd., Instrumentation Laboratory (Werfen), Medica Corporation, OPTI Medical, Radiometer, Siemens AG, Nova Biomedical, and Tecom Analytical system. These industry participants are implementing various growth strategies with continued innovations and technology improvements to sustain market competition.
 

The blood gas and electrolyte analyzers market research report include an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:
 

Market, By Modality, 2017-2028 (USD Million)

• Bench top
• Portable

Market, By Product, 2017-2028 (USD Million)

• Blood gas analyzers
• Electrolyte analyzers
• Combined analyzers
• Consumables

Market, By End-use, 2017-2028 (USD Million)

• Central laboratories
• Point-of-care
• Diagnostic centers
• Hospitals
• Others

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific 
  • Japan
  • China
  • India
• Latin America 
  • Brazil
  • Mexico
• Middle East & Africa 
  • South Africa
  • Saudi Arabia